Firsthand Technology Value Fund Discloses Top Portfolio Holdings
Aug 11, 2017 20:15 pm UTC| Business
SAN JOSE, Calif., Aug. 11, 2017 -- Firsthand Technology Value Fund, Inc. (NASDAQ:SVVC) (the “Fund”), a publicly traded venture capital fund that invests in technology and cleantech companies, disclosed today that its...
ADMA Biologics Provides Corporate Update and Reports Second Quarter 2017 Financial Results
Aug 11, 2017 20:15 pm UTC| Business
RAMSEY, N.J., Aug. 11, 2017 -- ADMA Biologics, Inc. (NASDAQ:ADMA) (“ADMA” or the “Company”), a vertically integrated biopharmaceutical and specialty immunoglobulin company that develops, manufactures and markets...
Buckreef Gold Project Not Effected by New Laws in Tanzania
Aug 11, 2017 20:13 pm UTC| Business
TORONTO, Aug. 11, 2017 -- Tanzanian Royalty Exploration Corporation (TSX:TNX) (NYSE MKT:TRX) hereinafter (the "Company") announces that it is not affected by new laws in Tanzania. "The new mining laws in Tanzania...
Intuitive Surgical Board of Directors Approves a Three-for-One Stock Split
Aug 11, 2017 20:10 pm UTC| Business
SUNNYVALE, Calif., Aug. 11, 2017 -- Intuitive Surgical, Inc. (NASDAQ:ISRG), a global technology leader in robotic-assisted, minimally invasive surgery, today announced that its Board of Directors has approved a...
Towerstream Reports Second Quarter 2017 Results and Progress in Key Performance Indicators
Aug 11, 2017 20:08 pm UTC| Business
MIDDLETOWN, R.I., Aug. 11, 2017 -- Towerstream Corporation (OTCQB:TWER), a fixed wireless fiber alternative provider, today announced financial results for the second quarter ended June 30, 2017. OVERVIEW “We are...
Soleno Therapeutics Provides Corporate Update and Reports Second Quarter 2017 Financial Results
Aug 11, 2017 20:05 pm UTC| Business
Completed Successful FDA Meeting for DCCR in Prader-Willi SyndromePreparing to begin Phase III program by the end of the yearMonetized Non-Strategic Assets Through Sale of NeoForce, Inc. Subsidiary REDWOOD CITY, Calif.,...
miRagen Therapeutics Reports Second Quarter 2017 Financial Results and Provides Corporate Update
Aug 11, 2017 20:05 pm UTC| Business
New MRG-106 Phase 1 cutaneous T-cell lymphoma clinical trial data releasedExpansion of the MRG-106 trial to include additional potential indicationsTwo new independent members added to its Board of DirectorsConference call...
Australia’s Corporate Regulator Urges Pension Funds to Boost Technology Investment as Industry Grows